|
RPS6KB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83110193674452E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.78180001045803E-09 |
| Normal-vs-Stage2 |
1.52719999999551E-05 |
| Normal-vs-Stage3 |
2.46880293985896E-11 |
| Normal-vs-Stage4 |
2.87100343498992E-11 |
| Stage1-vs-Stage2 |
7.655800E-01 |
| Stage1-vs-Stage3 |
4.314200E-02 |
| Stage1-vs-Stage4 |
1.137630E-02 |
| Stage2-vs-Stage3 |
8.626200E-02 |
| Stage2-vs-Stage4 |
2.973800E-02 |
| Stage3-vs-Stage4 |
5.639200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.38562552729627E-12 |
| Normal-vs-AfricanAmerican |
1.515740E-03 |
| Normal-vs-Asian |
3.86179999978253E-07 |
| Caucasian-vs-AfricanAmerican |
2.027400E-01 |
| Caucasian-vs-Asian |
6.031800E-01 |
| AfricanAmerican-vs-Asian |
4.118000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.0503049499091E-11 |
| Normal-vs-Female |
2.2176005476382E-10 |
| Male-vs-Female |
5.505800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.04999999595412E-08 |
| Normal-vs-Age(41-60Yrs) |
2.02299954565888E-10 |
| Normal-vs-Age(61-80Yrs) |
7.00480007331805E-10 |
| Normal-vs-Age(81-100Yrs) |
3.033500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.418200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.147400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.432800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.958400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.568000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.076800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.618190E-03 |
| Classical-VS-Follicular |
7.836800E-01 |
| Classical-VS-Other |
4.795400E-01 |
| Classical-VS-Normal |
2.05359995675281E-09 |
| Tall-VS-Follicular |
1.414490E-02 |
| Tall-VS-Other |
4.682000E-01 |
| Tall-VS-Normal |
1.38980005282008E-09 |
| Follicular-VS-Other |
6.029200E-01 |
| Follicular-VS-Normal |
1.47910000003471E-06 |
| Other-VS-Normal |
4.244900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.95750004883655E-10 |
| Normal-vs-N1 |
2.45600000003954E-07 |
| N0-vs-N1 |
8.675600E-01 |
|
|
